Search by Journal

Neurological Therapeutics

Volume 37, Issue 6 / 2020
English Article   Japanese Article
  • Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Japanese Article In the holding of the 38th Japan neurotherapeutics association arts and sciences meeting
藤岡俊樹
Neurological Therapeutics 37(6): S9-S9, 2020.
Japanese Article Practice ... of the acupuncture needle moxibustion treatment for acupuncture needle moxibustion experience lecture (2) - intractable pain and the paralysis for experience-based practical skill seminar physicians
山口智
Neurological Therapeutics 37(6): S69-S69, 2020.
Japanese Article The present of the Japanese neurotherapeutics academic conference which moved forward with a member and the future
平田幸一
Neurological Therapeutics 37(6): S73-S73, 2020.
Japanese Article From treatment, Japan of the ALS to the world
三本博
Neurological Therapeutics 37(6): S75-S75, 2020.
English Article Targeting inflammatory cytokine dysregulation in multiple sclerosis
Cris Constantinescu
Neurological Therapeutics 37(6): S76-S76, 2020.
Japanese Article Efforts of regional alliances of the local inclusion care system and nervous disease of Setagaya-ku
太田雅也
Neurological Therapeutics 37(6): S77-S77, 2020.
Japanese Article Regional alliances of the nervous disease: Through Setagaya dementia network workshop
織茂智之
Neurological Therapeutics 37(6): S78-S78, 2020.
Japanese Article Relation of the regional alliances section in the Setagaya dementia network workshop
宇都宮勢津子
Neurological Therapeutics 37(6): S79-S79, 2020.
Japanese Article Dementia regional alliances ... judging from regional alliances ... case that we turn on Setagaya dementia network workshop
清塚鉄人
Neurological Therapeutics 37(6): S80-S80, 2020.
Japanese Article Through patients with regional alliances Setagaya at-home intractable disease visit practice business of the nervous disease from efforts and the change of the business, the situation of the Primary care physician
大坪孝一
Neurological Therapeutics 37(6): S81-S81, 2020.
Japanese Article It is ... through a relation to patients with "prospects of a role and the future of the temporary nursing at home in the area" - Setagaya-ku at-home intractable disease visit practice business
柳町かんな
Neurological Therapeutics 37(6): S82-S82, 2020.
Japanese Article Relation of the life support center local through patients with Setagaya at-home intractable disease visit practice business
上原孝一
Neurological Therapeutics 37(6): S83-S83, 2020.
Japanese Article Role as Setagaya-ku to support at-home patients with intractable disease and a severe person with a disability in an area
林英治
Neurological Therapeutics 37(6): S84-S84, 2020.
Japanese Article Merits and demerits ... which specializes sports ... single item of the children of the growth phase early
平野裕一
Neurological Therapeutics 37(6): S85-S85, 2020.
Japanese Article Trap of the skill acquisition of children judging from rhythmic gymnastics
秋山エリカ1, 有吉芳江2
Neurological Therapeutics 37(6): S86-S86, 2020.
Japanese Article The best coordination motion making brain, the nerve of children wake
泉原嘉郎
Neurological Therapeutics 37(6): S87-S87, 2020.
Japanese Article Current status of the academic invention for neurotherapeutics in Japan, and collaboration between JSNT and ASENT
中村治雅
Neurological Therapeutics 37(6): S88-S88, 2020.
English Article ASENT and JSNT : Continuing and Growing Collaboration
Kenneth W Sommerville1, Thomas Sutula2
Neurological Therapeutics 37(6): S89-S89, 2020.
Japanese Article About the current situation and a problem of the therapeutic drug development of the rare nervous disease domain
竹内芙実
Neurological Therapeutics 37(6): S90-S90, 2020.
Japanese Article Efforts of the AMED intractable disease practical use study business
滝澤歩武
Neurological Therapeutics 37(6): S91-S91, 2020.
English Article The industry perspective on challenges and status of drug development in rare neurological diseases
Hahn-Ey Lee1,2, Stephen Kagan2, Helene Schluep2, Yoko Fujimoto2, Dirk Vandermijnsbrugge2
Neurological Therapeutics 37(6): S92-S92, 2020.
Japanese Article The current situation and problem of "the phase II physician-led trial of NKT cells target glucide and lipid OCH-NCNP1 for patients with recurrent multiple sclerosis"
岡本智子1,2, 佐藤和貴郎2,3, 林幼偉1,2, 清水玲子4, 朝比奈泰子4, 中村治雅4, 高橋祐二1, 山村隆2,3
Neurological Therapeutics 37(6): S93-S93, 2020.
Japanese Article Clinical with the basics of nucleic acid medical care (the general remarks)
横田隆徳
Neurological Therapeutics 37(6): S94-S94, 2020.
Japanese Article Nucleic acid medical care for the spinal muscular atrophy
勝野雅央, 佐橋健太郎
Neurological Therapeutics 37(6): S95-S95, 2020.
Japanese Article Nucleic acid medicine for the Duchenne muscular dystrophy
永田哲也
Neurological Therapeutics 37(6): S96-S96, 2020.
Japanese Article Nucleic acid medicine of the Fukuyama type muscular dystrophy symptom
戸田達史
Neurological Therapeutics 37(6): S97-S97, 2020.
Japanese Article Nucleic acid medicine of the Parkinson's disease
望月秀樹
Neurological Therapeutics 37(6): S98-S98, 2020.
Japanese Article Exxon skip treatment of the Duchenne muscular dystrophy
青木吉嗣
Neurological Therapeutics 37(6): S99-S99, 2020.
Japanese Article The condition of a patient elucidation using the model mouse of the Fukuyama type muscular dystrophy and development of the treatment strategy
金川基1, 戸田達史2
Neurological Therapeutics 37(6): S100-S100, 2020.
Japanese Article Development of the therapy for Dysferlinopathy
小野洋也1,2, 鈴木直輝1, 菅野新一郎3, 川原玄理4, 割田仁1, 林由起子4, 三宅克也5, 青木正志1
Neurological Therapeutics 37(6): S101-S101, 2020.
Japanese Article Therapy for Collagen VI myopathy development
野口悟
Neurological Therapeutics 37(6): S102-S102, 2020.
Japanese Article Therapy development of the myotonica dystrophia
中森雅之
Neurological Therapeutics 37(6): S103-S103, 2020.
Japanese Article Operational results - of interhospital cooperation five years in medical institution cooperation - Southwest Tokyo Ward of the acute phase clot collection therapy in the metropolis
林盛人1, 藤田聡1, 平元侑1, 木原英雄4, 内孝文1, 稲葉彰2, 齋藤和幸3, 和田義明3, 安富大祐4, 中村芳樹4, 入江是明5, 吉田賢作6, 渡邊玲7, 佐藤章7, 小野健一郎8, 小松原弘9, 深作和明10, 松嶋茉莉1, 藤岡俊樹1, 岩渕聡1
Neurological Therapeutics 37(6): S104-S104, 2020.
Japanese Article It is ... from an example of efforts - Kochi to the spread of treatment for the cerebral infarction acute phase in the local city
太田剛史1, 政平訓貴2, 福田真紀2
Neurological Therapeutics 37(6): S105-S105, 2020.
Japanese Article The Yokohama-shi cerebrovascular disease emergency care system that passed through ten years after the start
山口滋紀1, 山本正博2, 北村佳久3
Neurological Therapeutics 37(6): S106-S106, 2020.
Japanese Article Kanagawa stroke wide area seamless medical workshop toward the path common throughout an every prefecture
高橋竜哉
Neurological Therapeutics 37(6): S107-S107, 2020.
Japanese Article Rehabilitation medical care cooperation in the stroke acute phase
尾花正義
Neurological Therapeutics 37(6): S108-S108, 2020.
Japanese Article Anticomplement and neurologic infection
亀井聡
Neurological Therapeutics 37(6): S109-S109, 2020.
Japanese Article Autoimmune encephalitis after the herpes simplex encephalitis: Clinical picture and pathophysiology
原誠
Neurological Therapeutics 37(6): S110-S110, 2020.
Japanese Article The prospects of the spread prevention and the therapy development of the prion disease
浜口毅, 山田正仁
Neurological Therapeutics 37(6): S111-S111, 2020.
Japanese Article The condition of a patient and treatment of the progressive multifocal leukoencephalopathy
三浦義治
Neurological Therapeutics 37(6): S112-S112, 2020.
Japanese Article The recent trend and prospects in the Parkinson's disease treatment
馬場徹1,2
Neurological Therapeutics 37(6): S113-S113, 2020.
Japanese Article The current situation and the prospects of the Parkinson's disease treatment that assumed synuclein a target
中森雅之
Neurological Therapeutics 37(6): S114-S114, 2020.
Japanese Article A genome medical science study of the Parkinson's disease and new drug discovery
佐竹渉1,2, 上中健2, PC Cha2, 戸田達史1
Neurological Therapeutics 37(6): S115-S115, 2020.
Japanese Article The current situation and the prospects of the precision medicine
大垣光太郎1, 服部信孝2
Neurological Therapeutics 37(6): S116-S116, 2020.
Japanese Article The current situation and the future prospects of the dementia practice
冨本秀和
Neurological Therapeutics 37(6): S117-S117, 2020.
Japanese Article Approach around Aβ
小野賢二郎
Neurological Therapeutics 37(6): S118-S118, 2020.
Japanese Article Amyloid, cell death in cells in the Alzheimer condition of a patient, temporal relationship of the extracellular amyloid condensation
岡澤均
Neurological Therapeutics 37(6): S119-S119, 2020.
Japanese Article About a diagnosis, therapeutic drug development in consideration of diversity of the tauopathy - current situation and future fine-view -
佐原成彦
Neurological Therapeutics 37(6): S120-S120, 2020.
Japanese Article The lower, the better? ... depression treatment and stroke prevention of recurrence
北川一夫
Neurological Therapeutics 37(6): S121-S121, 2020.
Japanese Article The lower, the better? LDL cholesterol drop therapy and stroke prevention of recurrence
伊藤義彰
Neurological Therapeutics 37(6): S122-S122, 2020.
Japanese Article Less is more? In combination with the choice of ... antithrombotic drug
板橋亮
Neurological Therapeutics 37(6): S123-S123, 2020.
Japanese Article Minesweeper - brain microhemorrhage and antithrombotic therapy
藥師寺祐介1, 原英夫1,2
Neurological Therapeutics 37(6): S124-S124, 2020.
Japanese Article Approach ... to The long and winding road - carotid artery constriction
山上宏
Neurological Therapeutics 37(6): S125-S125, 2020.
Japanese Article The current situation and the prospects of hereditary ATTR amyloidosis treatment
植田光晴
Neurological Therapeutics 37(6): S126-S126, 2020.
Japanese Article The current situation of the treatment study of Charcot-Marie-Tooth disease
岡本裕嗣
Neurological Therapeutics 37(6): S127-S127, 2020.
Japanese Article Disease ornamentation therapy in line with a diagnosis and the condition of a patient for cerebrotendinous xanthomatosis
小山信吾
Neurological Therapeutics 37(6): S128-S128, 2020.
Japanese Article Adaptation and the effectiveness of the hematopoietic stem cell transplantation for the adrenoleukodystrophy
松川敬志
Neurological Therapeutics 37(6): S129-S129, 2020.
Japanese Article Of the Nusinersen treatment of the spinal muscular atrophy, actually
橋口昭大
Neurological Therapeutics 37(6): S130-S130, 2020.
Japanese Article Multiple sclerosis: Life-style related diseases hypothesis and gut flora
山村隆
Neurological Therapeutics 37(6): S131-S131, 2020.
Japanese Article The pathology condition of a patient and treatment of NMOSD and the MOG antibody associated diseases
三須建郎
Neurological Therapeutics 37(6): S132-S132, 2020.
Japanese Article Autoantibody-mediated neuropathic pain and immunotherapy
藤井敬之
Neurological Therapeutics 37(6): S133-S133, 2020.
Japanese Article Remedial significance of Sema4A in inflammatory demyelinating diseases
奥野龍禎
Neurological Therapeutics 37(6): S134-S134, 2020.
Japanese Article Possibility of nucleic acid medicine in the immune-mediated neuriatria
横田隆徳
Neurological Therapeutics 37(6): S135-S135, 2020.
Japanese Article Insomniac nerve therapeutics
北島剛司
Neurological Therapeutics 37(6): S136-S136, 2020.
Japanese Article Nerve therapeutics of the sleep apnoea
角谷寛
Neurological Therapeutics 37(6): S137-S137, 2020.
Japanese Article Nerve therapeutics of RLS
鈴木圭輔
Neurological Therapeutics 37(6): S138-S138, 2020.
Japanese Article Central hypersomnia and developmentally disabled association and those treatment
神林崇1,2, 今西彩3, 石戸秀明1,4, 大森佑貴5, 富永杜絵1, 小野太輔6, 西野精治6, 近藤英明1,7
Neurological Therapeutics 37(6): S139-S139, 2020.
Japanese Article Nerve therapeutics of the REM sleep behavior disorder
角幸頼1, 松尾雅博1, 尾関祐二1, 角谷寛2
Neurological Therapeutics 37(6): S140-S140, 2020.
Japanese Article Advanced MRI in Parkinson's disease
鎌形康司
Neurological Therapeutics 37(6): S141-S141, 2020.
Japanese Article About the characteristic of the nerve image in the neurodegenerative disease that you should suppress, pit fall
徳丸阿耶
Neurological Therapeutics 37(6): S142-S142, 2020.
Japanese Article The current situation of the amyloid tau PET and new probe development
岡村信行
Neurological Therapeutics 37(6): S143-S143, 2020.
Japanese Article Animal models of the progressive form multiple sclerosis and the application
山村隆, 大木伸司, Ben Raveney
Neurological Therapeutics 37(6): S144-S144, 2020.
Japanese Article Neuromyelitis optica associated diseases (NMOSD)
奥野龍禎
Neurological Therapeutics 37(6): S145-S145, 2020.
Japanese Article Ganglioside antibody-positive neuropathy
桑原基
Neurological Therapeutics 37(6): S146-S146, 2020.
Japanese Article The experimental treatments of animal models of the immune-mediated nerve, muscular disease: Demyelinating neuropathy
飯島正博
Neurological Therapeutics 37(6): S147-S147, 2020.
Japanese Article The development of the myasthenia gravis model animal and study of the therapy
重本和宏
Neurological Therapeutics 37(6): S148-S148, 2020.
Japanese Article Cognitive dysfunction of the MS and the evaluation
河内泉1,2
Neurological Therapeutics 37(6): S149-S149, 2020.
Japanese Article Brain atrophy of the MS and the evaluation
藤盛寿一
Neurological Therapeutics 37(6): S150-S150, 2020.
Japanese Article The MS treatment strategy which focused on neuroprotection
中原仁
Neurological Therapeutics 37(6): S151-S151, 2020.
Japanese Article A disease modifier and progressive multifocal leukoencephalopathy of the multiple sclerosis
三條伸夫
Neurological Therapeutics 37(6): S152-S152, 2020.
Japanese Article New progress in the diagnosis
金澤恭子
Neurological Therapeutics 37(6): S153-S153, 2020.
Japanese Article The improvement of antiepileptic drug and problems
杉浦嘉泰
Neurological Therapeutics 37(6): S154-S154, 2020.
Japanese Article Epilepsy surgical treatment to want a neurologist to know it
岩崎真樹, 飯島圭哉, 高山裕太郎, 木村唯子, 金子裕
Neurological Therapeutics 37(6): S155-S155, 2020.
Japanese Article Now of epilepsy rehabilitation and the social system
藤川真由
Neurological Therapeutics 37(6): S156-S156, 2020.
Japanese Article The condition of a patient protein cohesion control effect of phenolic compounds derived from enteral flora
小野賢二郎
Neurological Therapeutics 37(6): S157-S157, 2020.
Japanese Article Attempt of the disease-specific cell model construction in an overhanging style and therapy development of a nerve, the line intractable disease
青木吉嗣
Neurological Therapeutics 37(6): S158-S158, 2020.
Japanese Article Treatment with new small molecule development for Huntington disease
中森雅之
Neurological Therapeutics 37(6): S159-S159, 2020.
Japanese Article Possibility of development and the treatment of the model of the early Parkinson's disease
山門穂高
Neurological Therapeutics 37(6): S160-S160, 2020.
Japanese Article Usefulness of the steroid (oral, steroid pulse)
鈴木靖士
Neurological Therapeutics 37(6): S161-S161, 2020.
Japanese Article Use in consideration of an adverse event of the steroid (oral, steroid pulse) in the myasthenia gravis
杉本太路1, 山脇健盛1,2, 越智一秀3, 郡山達男4
Neurological Therapeutics 37(6): S162-S162, 2020.
Japanese Article Usefulness of the non-steroid immunosuppressive drug
山本大輔
Neurological Therapeutics 37(6): S163-S163, 2020.
Japanese Article Adaptation and effect of the complement target medicine
寒川真
Neurological Therapeutics 37(6): S164-S164, 2020.
Japanese Article New trial of the CD20, CD19, FcRn target medicine
紺野晋吾
Neurological Therapeutics 37(6): S165-S165, 2020.
Japanese Article Of the activity as the intractable disease nurse, actually
花井亜紀子
Neurological Therapeutics 37(6): S166-S166, 2020.
Japanese Article Upbringing of the nurse specialized in the intractable disease nursing
中山優季
Neurological Therapeutics 37(6): S167-S167, 2020.
Japanese Article It is ... from the introduction of the Parkinson's disease nurse of expectation - foreign countries to Japanese intractable disease nurses
高橋一司
Neurological Therapeutics 37(6): S168-S168, 2020.
Japanese Article Pure autonomic nerve aplasia (Pure autonomic failure) and multiple system atrophy (so-called MSA-A)
山中義崇1,2
Neurological Therapeutics 37(6): S169-S169, 2020.
Japanese Article Autonomic nervous system disorders and pathology of Lewy corpusculum disease
吉田眞理
Neurological Therapeutics 37(6): S170-S170, 2020.
Japanese Article Autonomic nervous system disorders and pathology of the progressive supranuclear palsy
饗場郁子1, 吉田眞理2
Neurological Therapeutics 37(6): S171-S171, 2020.
Japanese Article The past, the present, the future of the autoimmune autonomic ganglion disorder
中根俊成
Neurological Therapeutics 37(6): S172-S172, 2020.
Japanese Article Autonomic nervous system disorders in trigeminal nerve, autonomy nervous headache (TACs)
古和久典
Neurological Therapeutics 37(6): S173-S173, 2020.
Japanese Article unmet needs of migraine headache treatment: Overview
竹島多賀夫
Neurological Therapeutics 37(6): S174-S174, 2020.
Japanese Article An antiCGRP antibody, an antiCGRP receptor antibody: From a clinical study to real-world data
辰元宗人1, 椎名智彦2, 鈴木紫布2, 平田幸一2
Neurological Therapeutics 37(6): S175-S175, 2020.
Japanese Article Development status of oral CGRP blocker gepant
柴田護
Neurological Therapeutics 37(6): S176-S176, 2020.
Japanese Article 5-HT1F agonist ditan: Living apart with mechanism of action and tripitan
今井昇
Neurological Therapeutics 37(6): S177-S177, 2020.
Japanese Article Migraine headache treatment by the noninvasive neuromodulation
團野大介
Neurological Therapeutics 37(6): S178-S178, 2020.
Japanese Article Of chemotherapy-induced peripheral neuropathy (CIPN: Chemotherapy induced peripheral neuropathy) examine; a person
関口縁
Neurological Therapeutics 37(6): S179-S179, 2020.
Japanese Article Neurologic immune-mediated adverse event with the immune checkpoint inhibitor
谷口洋1, 坂本剛2, 鈴木重明3
Neurological Therapeutics 37(6): S180-S180, 2020.
Japanese Article The development of progressive multifocal leukoencephalopathy with the disease modifier in the multiple sclerosis
吉良潤一
Neurological Therapeutics 37(6): S181-S181, 2020.
Japanese Article Drug-related parkinsonism dyskinesia
冨山誠彦
Neurological Therapeutics 37(6): S182-S182, 2020.
Japanese Article Eating dysphagia of the Parkinson's disease
山本敏之
Neurological Therapeutics 37(6): S183-S183, 2020.
Japanese Article The actual situation and rehabilitation of dysphagia associated with the ALS
市原典子
Neurological Therapeutics 37(6): S184-S184, 2020.
Japanese Article Dysphagia to work on by an at-home team
奥山光子1, 荻野美恵子2
Neurological Therapeutics 37(6): S185-S185, 2020.
Japanese Article The actual situation and rehabilitation (Japan and the United States) of eating dysphagia
倉智雅子
Neurological Therapeutics 37(6): S186-S186, 2020.
Japanese Article The latest trend of the MS/NMO treatment
三須建郎
Neurological Therapeutics 37(6): S187-S187, 2020.
Japanese Article Up to Date in autoimmune encephalitis and the relation disease
飯塚高浩
Neurological Therapeutics 37(6): S188-S188, 2020.
Japanese Article Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
倉恒弘彦
Neurological Therapeutics 37(6): S189-S189, 2020.
Japanese Article A diagnosis of autoimmune encephalitis, encephalopathy and progress of the treatment
米田誠
Neurological Therapeutics 37(6): S190-S190, 2020.
Japanese Article Treatment (from practice guidelines 2017) of multiple sclerosis - complications
清水優子
Neurological Therapeutics 37(6): S191-S191, 2020.
Japanese Article The sarcoidosis that a cranial nerve physician should examine
西山和利
Neurological Therapeutics 37(6): S192-S192, 2020.
Japanese Article Drug choice of the Parkinson's disease with complications
飯嶋睦
Neurological Therapeutics 37(6): S193-S193, 2020.
Japanese Article The basics and application of Deep Brain Stimulation
下泰司
Neurological Therapeutics 37(6): S194-S194, 2020.
Japanese Article Nerve, line allied adverse event of immunity
鈴木重明
Neurological Therapeutics 37(6): S195-S195, 2020.
Japanese Article Cerebrovascular disorder latest treatment 2020
平野照之
Neurological Therapeutics 37(6): S196-S196, 2020.
Japanese Article Alzheimer's disease treatment - current situation and future fine-view ...
下濱俊
Neurological Therapeutics 37(6): S197-S197, 2020.
Japanese Article Medical treatment of the migraine headache
柴田護
Neurological Therapeutics 37(6): S198-S198, 2020.
Japanese Article GBS latest treatment
桑原基
Neurological Therapeutics 37(6): S199-S199, 2020.
Japanese Article CIDP: The latest treatment
飯島正博
Neurological Therapeutics 37(6): S200-S200, 2020.
Japanese Article Management of the pregnancy and the childbirth of patients with immunologic nervous disease
野原千洋子
Neurological Therapeutics 37(6): S201-S201, 2020.
Japanese Article A viewpoint and way of thinking of the examination for evoked response
赤松直樹
Neurological Therapeutics 37(6): S202-S202, 2020.
Japanese Article Treatment for the gait disturbance of the Parkinson's disease
赫寛雄, 相澤仁志
Neurological Therapeutics 37(6): S203-S203, 2020.
Japanese Article MRI of the spinal disease
堀正明, 神谷昂平, 鈴木賢一, 高橋木綿子
Neurological Therapeutics 37(6): S204-S204, 2020.
Japanese Article The main point of the respiratory care of neuromuscular disorders
鈴木幹也
Neurological Therapeutics 37(6): S205-S205, 2020.
Japanese Article Epilepsy treatment 2020
松本理器
Neurological Therapeutics 37(6): S206-S206, 2020.
Japanese Article Differentiation and treatment of the dizziness and the latest topic
城倉健
Neurological Therapeutics 37(6): S207-S207, 2020.
Japanese Article Trend - of treatment - these days of the myasthenia gravis
紺野晋吾
Neurological Therapeutics 37(6): S208-S208, 2020.
Japanese Article Urinary tract management for the neurogenic bladder: It is urologic, and what is a point?
関戸哲利
Neurological Therapeutics 37(6): S209-S209, 2020.
Japanese Article Continence care for comfortable bowel movements of patients with nervous disease
榊原千秋
Neurological Therapeutics 37(6): S210-S210, 2020.
Japanese Article Rating system of eating dysphagia in the bedside
野崎園子
Neurological Therapeutics 37(6): S211-S211, 2020.
Japanese Article Nervous disease and sleep disorder
野村哲志
Neurological Therapeutics 37(6): S212-S212, 2020.
Japanese Article The basics of nutrition therapy of the neurodegenerative disease
下畑享良
Neurological Therapeutics 37(6): S213-S213, 2020.
Japanese Article A lifestyle, life-style related diseases and Alzheimer's disease
山崎貴史1,2
Neurological Therapeutics 37(6): S214-S214, 2020.
Japanese Article Assessment and care of elderly people with dementia that there is because it is a regular hospital nurse
橋本裕
Neurological Therapeutics 37(6): S215-S215, 2020.
Japanese Article The role of the Parkinson's disease nurse and the overseas current situation
関守信
Neurological Therapeutics 37(6): S216-S216, 2020.
Japanese Article ALS clinic of the half day course carried out in One team
狩野修
Neurological Therapeutics 37(6): S217-S217, 2020.
Japanese Article AOD1-1. Neurologic abnormal and neurologic prognostic examination in COVID-19
石山浩之, 石井淳子, 角替麻里絵, 尾原信行, 吉村元, 幸原伸夫, 川本未知
Neurological Therapeutics 37(6): S221-S221, 2020.
Japanese Article AOD1-2. Characteristic of the neurologic aftereffects and cerebral blood flow SPECT in the COVID-19 severe case
塩見悠真, 石山浩之, 石井淳子, 比谷里美, 乾涼磨, 中澤晋作, 黒田健仁, 角替麻里絵, 藤原悟, 村上泰隆, 前川嵩太, 尾原信行, 吉村元, 幸原伸夫, 川本未知
Neurological Therapeutics 37(6): S221-S221, 2020.
English Article AOD1-3. Global Open-label Extension : 24-month Data of Patisiran in Patients with hATTR Amyloidosis
植田光晴1, D Adams2, A Gonzalez-Duarte3, E Mauricio4, T Brannagan5, T Coelho6, J Wixner7, H Schmidt8, M Berber9, M Sweetser9, M White9, JJ Wang9, M Polydefkis10
Neurological Therapeutics 37(6): S221-S221, 2020.
English Article AOD1-4. Long-term integrated patisiran safety in patients with hATTR amyloidosis with polyneuropathy
関島良樹1, J Gillmore2, J Berk3, A Dispenzieri4, M Polydefkis5, A Gonzalez-Duarte6, M Sweetser7, S Arum7, JJ Wang7, M White7, M Maurer8
Neurological Therapeutics 37(6): S221-S221, 2020.
English Article AOD1-5. Impact of Patisiran on Activities of Daily Living and Functional Status in hATTR Amyloidosis
山下太郎1, A Peltier2, A Gonzalez-Duarte3, J Berk4, I Tournev5, OB Suhr6, S Ajroud-Driss7, M Merkel8, H Lin8, C Hale8, D Adams9
Neurological Therapeutics 37(6): S222-S222, 2020.
Japanese Article AOD1-6. Clinical picture of severe polyradiculoneuropathy which occurred by checkpoint inhibitor administration of immunity
岡田健佑1, 関守信1, 谷口洋2, 作田健一2, 向井泰司2, 山田哲3, 大木宏一3, 中原仁1, 鈴木重明1
Neurological Therapeutics 37(6): S222-S222, 2020.
Japanese Article AOD1-7. A characteristic and treatment response of cranial nerve palsies in chronic inflammatory demyelinating polyneuropathy
澁谷和幹, 常山篤子, 三澤園子, 水地智基, 鈴木陽一, 小島雄太, 中村圭吾, 狩野裕樹, Mario Prado, 桑原聡
Neurological Therapeutics 37(6): S222-S222, 2020.
Japanese Article AOD1-8. Painful evaluation of patients with amyotrophic lateral sclerosis using the ALS palliative care scale
清水俊夫1,2, 木村英紀1,2, 森島亮1,2, 木田耕太1,2, 清水尚子2, 小野崎香苗2, 新井玉南2, 工藤芽衣子2, 早乙女貴子2, 笠原良雄2, 本間武蔵2, 原田明子2, 阪口優理2, 高橋一司1
Neurological Therapeutics 37(6): S222-S222, 2020.
Japanese Article AOD1-9. Usefulness of the quantitative susceptibility mapping image in the brain depth stimulation therapy
松浦慶太1,2, 伊井裕一郎1, 前田正幸3, 佐藤正之4, 田部井賢一5, 新堂晃大1, 海野真記6, 梶川博之2, 荒木朋浩7, 冨本秀和1
Neurological Therapeutics 37(6): S223-S223, 2020.
Japanese Article AOD1-10. Significance of the noise pareidolia test in the Parkinson's disease patients
大本周作, 村上秀友, 白石朋敬, 梅原淳, 井口保之
Neurological Therapeutics 37(6): S223-S223, 2020.
Japanese Article AOD1-12. Testicular participation in the case of NMDA receptor encephalitis for men
平野牧人1, 井上貴美子2, 伊藤龍生3, 寒川真1, 藤村晴俊4, 能勢和宏5, 楠進1, 中村雄作6
Neurological Therapeutics 37(6): S223-S223, 2020.
Japanese Article AOD1-13. Examination of the effectiveness of the antiepileptic drug in old onset epilepsy in our hospital
大矢佳奈子, 田中章浩, 水野敏樹
Neurological Therapeutics 37(6): S224-S224, 2020.
Japanese Article OD1-1. One case of the Parkinson's disease which abnormal posture improved by rasagiline administration
平山剛久1, 小中宏美2, 郡司義尊2, 岩本康之介2, 清塚鉄人2, 狩野修1
Neurological Therapeutics 37(6): S225-S225, 2020.
Japanese Article OD1-2. One patient who needed invention for maneuver acquisition, and the like after the LCIG introduction
花城里依1,2, 狩野修1, 給前まや1, 蝦名潤哉1, 川邉清一1
Neurological Therapeutics 37(6): S225-S225, 2020.
Japanese Article OD1-3. Comparison between effect - selegiline and rasagiline of the MAO-B inhibitor in the initial treatment of Parkinson disease
村上秀友, 小澤正和, 白石朋敬, 梅原淳, 大本周作, 井口保之
Neurological Therapeutics 37(6): S225-S225, 2020.
Japanese Article OD1-4. The overactive bladder of the person with Parkinson disease of the first is associated with orthostatic hypotension
小澤正和, 村上秀友, 白石朋敬, 梅原淳, 大本周作, 井口保之
Neurological Therapeutics 37(6): S225-S225, 2020.
Japanese Article OD1-5. Association between blood essential fatty acid concentration and clinical manifestations in the De novo Parkinson's disease
梅原淳1, 白石朋敬1, 中原淳夫2, 松野博優1, 大本周作1, 村上秀友1, 岡尚省2, 井口保之1
Neurological Therapeutics 37(6): S226-S226, 2020.
Japanese Article OD1-6. On the other side of early diagnosis - clinical department cooperation of the synucleinopathy
榊原隆次, 舘野冬樹, 相羽陽介, 尾形剛
Neurological Therapeutics 37(6): S226-S226, 2020.
Japanese Article OD2-1. Importance of the early treatment intervention with recurrent number of times and disease modifier in the brain atrophy progress of patients with multiple sclerosis
枡田大生, 森雅裕, 鵜沢顕之, 内田智彦, 大谷龍平, 青木玲二, 桑原聡
Neurological Therapeutics 37(6): S227-S227, 2020.
Japanese Article OD2-2. The gray matter atrophy in patients with secondary progressive form multiple sclerosis, a body function disorder, the association of the cognitive function: EXPAND test results
越智博文
Neurological Therapeutics 37(6): S227-S227, 2020.
Japanese Article OD2-4. Safety of natalizumab in patients with multiple sclerosis and the effectiveness: Than an interim analysis of the the fifth-year use results investigation
横山和正1, 齋田孝彦2, 神田三智弘3, 佐藤竜介3, 牧岡大器3, 金明寿3
Neurological Therapeutics 37(6): S227-S227, 2020.
Japanese Article OD2-5. Than an expression of safe examination matter situation - use results investigation interim report in the fumarate dimethyl pharmaceutical products risk management plan
横山和正1, 深澤俊行2, 中島一郎3, 佐藤竜介4, 牧岡大器4, 佐藤弥生4, 金明寿4, 山村隆5
Neurological Therapeutics 37(6): S228-S228, 2020.
Japanese Article OD2-7. CD20 antibody (Ofatumumab) APOLITOS study for Japan and patients with recurrent type multiple sclerosis of Russia
丸山サラディーニ惠子
Neurological Therapeutics 37(6): S228-S228, 2020.
Japanese Article OD3-1. Plant; the current situation of acute phase cerebral infarction treatment of the patients with the type heart electricity device
早津仁美1, 加藤裕司1, 林健1, 加藤律史2, 内野晃3, 高尾昌樹1, 高橋愼一1
Neurological Therapeutics 37(6): S229-S229, 2020.
Japanese Article OD3-2. One case of the RNF213 p.R4810K genetic polymorphism-positive acute brain chief editor artery obstruction which repeated reocclusion after the clot collection
吉本武史, 福間一樹, 田中智貴, 鷲田和夫, 服部頼都, 猪原匡史
Neurological Therapeutics 37(6): S229-S229, 2020.
Japanese Article OD3-3. The 80 years old women case whom delayed leukoencephalopathy developed in after the endovascular treatment for the cerebral infarction for acute phase
水間敦士, 湯谷佐知子, 今関良子, 永田栄一郎, 瀧澤俊也
Neurological Therapeutics 37(6): S229-S229, 2020.
Japanese Article OD3-4. Clinical examination of a solidification marker and the comming to hospital time disease severity of patients with cardioembolic that occurred during oral anticoagulant drug remedy directly
藤田宗吾, 出口一郎, 長田高志, 高尾昌樹, 高橋愼一
Neurological Therapeutics 37(6): S229-S229, 2020.
Japanese Article OD3-5. Examination of the aspiration pneumonia merger case in the acute phase ischemic stroke
秋本高義, 廣瀬聡, 溝口知孝, 横田優樹, 二宮智子, 原誠, 石原正樹, 森田昭彦, 中嶋秀人
Neurological Therapeutics 37(6): S230-S230, 2020.
Japanese Article OD3-6. The 56 years old men with severe atopic dermatitis case who presented with multiple cerebral infarction during the course
浅原有揮1, 宮川晋治2, 鈴木正彦1
Neurological Therapeutics 37(6): S230-S230, 2020.
Japanese Article OD3-7. One case of the cerebral infarction by the posterior inferior cerebellar artery dissection which a neurologic symptom aggravated on the ninth day of illness
小池大吾1, 突田健一1, 渡辺源也1, 佐藤一輝1, 山本尚輝1, 川崎永美子1, 栗原紀子2, 鈴木靖士1
Neurological Therapeutics 37(6): S230-S230, 2020.
Japanese Article OD4-1. Lumbar lesion identification by the examination for pallesthesia
大津留翔1, 永松秀一1, 笹ヶ迫直一2, 古谷博和1
Neurological Therapeutics 37(6): S231-S231, 2020.
Japanese Article OD4-2. One case of Neuropsychiatric systemic lupus erythematosus (NPSLE) who had Guillain-Barre syndrome
松尾宏俊1, 田中章浩1,2
Neurological Therapeutics 37(6): S231-S231, 2020.
Japanese Article OD4-3. One case that MR neurography was useful for a diagnosis and an effect of treatment judgment of the distal type idiopathy brachial plexus flame
長尾龍之介, 新美芳樹, 島さゆり, 水谷泰彰, 植田晃広, 伊藤瑞規, 渡辺宏久
Neurological Therapeutics 37(6): S231-S231, 2020.
Japanese Article OD4-4. One case of the POEMS syndrome where there was no serum M protein in: Consideration about a diagnosis and the treatment
鳥居良太1, 土方靖浩1, 坪井崇1, 熱田直樹1, 小池春樹1, 中村友彦2, 勝野雅央1
Neurological Therapeutics 37(6): S231-S231, 2020.
Japanese Article OD4-5. Association between initial treatment for peripheral neuropathy and long term prognosis associated with the acidophilic polyangiitis-related granulomatosis
森島亮1, 清水俊夫1, 頼母木直樹2, 横川直人2, 高橋一司1
Neurological Therapeutics 37(6): S232-S232, 2020.
Japanese Article OD4-6. The 72 years old women case who made induction of remission with rituximab for cerebral infarction, microscopic polyangiitis with peripheral neuropathy
鏑木圭1, 伊佐早健司1, 鈴木祐1,2, 佐々木直1, 長谷川泰弘1,2, 山野嘉久1
Neurological Therapeutics 37(6): S232-S232, 2020.
Japanese Article OD5-1. One case of antiCCP antibody-positive rheumatic meningitis without the joint symptom that led to the malignant tumor discovery
尾上祐行1, 林瑞香1, 高野一成2, 沼畑恭子1, 小川知宏1, 赤岩靖久1, 宮本智之1
Neurological Therapeutics 37(6): S233-S233, 2020.
Japanese Article OD5-2. Examination of the treatment response of rheumatic meningitis that we experienced in our hospital
花岡康子, 池田淳司, 高曽根健, 下島恭弘, 関島良樹
Neurological Therapeutics 37(6): S233-S233, 2020.
Japanese Article OD5-3. Association between clinical picture and treatment of the hyperplastic pachymeningitis
山本眞梨江1, 武田景敏1, 難波広人2, 青原健太3, 三野俊和1, 根来伸夫4, 伊藤義彰1
Neurological Therapeutics 37(6): S233-S233, 2020.
Japanese Article OD5-4. The 59 years old men with nerve sarcoidosis case that we presented with cerebellum ataxia and transient dysarthria, and Parkinson's disease, lacunar infarction was suspected in
菊池崇之1, 伊佐早健司1, 佐々木直1, 長谷川泰弘1,2, 山野嘉久1
Neurological Therapeutics 37(6): S233-S233, 2020.
Japanese Article OD5-5. The 44 years old women with nerve sarcoidosis case that a radicular thickening was detected in MRI and diagnosed by renal biopsy
羽田貴礼, 森嶋悠人, 諏訪裕美, 佐竹紅音, 高紀信, 長坂高村, 新藤和雅, 瀧山嘉久
Neurological Therapeutics 37(6): S234-S234, 2020.
Japanese Article OD5-6. Effect of treatment judgment index of the nerve sarcoidosis that presented hydrocephalus
長山成美, 中西恵美, 松井真
Neurological Therapeutics 37(6): S234-S234, 2020.
Japanese Article OD5-7. One case of the nerve sarcoidosis that we had the onset for hydrocephalus, and a shunting was successful
新井萌子1, 突田健一1, 渡辺源也1, 大友莉那1, 佐藤一輝1, 山本尚輝1, 川崎永美子1, 井上敬2, 岡直美3, 鈴木博義3, 栗原紀子4, 鈴木靖士1
Neurological Therapeutics 37(6): S234-S234, 2020.
Japanese Article OD6-1. One temporal lobe epilepsy with the progressive amygdaloid body swelling that gave Lacosamide, and was improved
池田宗平, 福間一樹, 石山浩之, 細木聡, 田中智貴, 猪原匡史
Neurological Therapeutics 37(6): S235-S235, 2020.
Japanese Article OD6-2. Examination of the antiepileptic drug for the status epilepticus of the pediatric alternation-related hemiplegia adults case with the ATP1A3 gene p.D801N mutation
海永光洋, 佐藤ももか, 吉田千晴, 小巻奨吾, 石浦浩之, 作石かおり, 岩田淳, 戸田達史
Neurological Therapeutics 37(6): S235-S235, 2020.
Japanese Article OD6-3. Examination of the effectiveness of Lacosamide in our hospital
松浦啓, 田中章浩, 大矢佳奈子, 水野敏樹
Neurological Therapeutics 37(6): S235-S235, 2020.
Japanese Article OD6-4. One case of the essential tremor which performed the bilateral thalamotomy by the MRI guide lower convergence supersonic wave
伊藤恒1, 山本一徹2, 青木蕉1, 福武滋1, 小渡貴司1, 亀井徹正1
Neurological Therapeutics 37(6): S235-S235, 2020.
Japanese Article OD6-5. One case of depression, aphonia and the diagnosed Wilson's disease
中村直子, 谷口彰, 新堂晃大, 冨本秀和
Neurological Therapeutics 37(6): S236-S236, 2020.
Japanese Article OD6-6. GDF15 and FGF21 in the adult mitochondrial illness
足立拓馬, 安藤匡宏, 湯地美佳, 平松有, 田代雄一, 崎山佑介, 岡本裕嗣, 松浦英治, 高嶋博
Neurological Therapeutics 37(6): S236-S236, 2020.
Japanese Article OD7-1. Caveolin -3/nNOS interaction: Base study for the muscular dystrophy treatment
大澤裕1, 白河俊一1, 丹田和恵1, 藤野雅広2, 西松伸一郎3, 砂田芳秀1
Neurological Therapeutics 37(6): S237-S237, 2020.
Japanese Article OD7-2. The effectiveness of the salbutamol single agent administration for the slow channel syndrome with the new CHRND mutation in the gene
山下賢1, 俵望1, 高松孝太郎1, 山崎義宗1, 向野晃弘1, 中根俊成1, 大野欽司2
Neurological Therapeutics 37(6): S237-S237, 2020.
Japanese Article OD7-3. Usefulness (case report) of the branched-chain amino acid for steroid myopathy
吉田暉, 細川裕子, 山西祐輝, 多田聡, 安藤利奈, 永井将弘
Neurological Therapeutics 37(6): S237-S237, 2020.
Japanese Article OD7-4. HLA-DRB1 genetic polymorphism and autoantibody in the Japanese inclusion body myositis
大山宗徳1, 大貫優子2, 井上道雄3, 漆葉章典4, 山下賢5, 湯谷佐知子6, Jantima Tanboon3, 中原仁1, 鈴木進悟7, 椎名隆7, 西野一三2, 鈴木重明1
Neurological Therapeutics 37(6): S237-S237, 2020.
Japanese Article OD7-5. One case of the eyes pharynx type muscular dystrophy which was able to close gastric fistula by the trachea larynx separation technique
岩田麻衣1, 井口洋平1, 熱田直樹1, 西野一三2, 勝野雅央1
Neurological Therapeutics 37(6): S238-S238, 2020.
Japanese Article OD7-6. Examination of the treatment for acromegalic myopathy and arthropathy which occurred after the nasal transsphenoid sinus operations (Hardy surgery)
佐々木諒, 山下徹, 高橋義秋, 阿部康二
Neurological Therapeutics 37(6): S238-S238, 2020.
Japanese Article OD8-1. Cranial nerve internal medicine practice in the COVID-19 season
藤原悟, 比谷里美, 乾涼磨, 塩見悠真, 中澤晋作, 黒田健仁, 角替麻里絵, 石山浩之, 石井淳子, 吉村元, 幸原伸夫, 川本未知
Neurological Therapeutics 37(6): S239-S239, 2020.
Japanese Article OD8-2. Characteristic of the examination for nerve conduction which presented abnormality after COVID-19 incidence
黒田健仁, 石井淳子, 石山浩之, 比谷里美, 乾涼磨, 塩見悠真, 中澤晋作, 角替麻里絵, 藤原悟, 前川嵩太, 村上泰隆, 尾原信行, 吉村元, 幸原伸夫, 川本未知
Neurological Therapeutics 37(6): S239-S239, 2020.
Japanese Article OD8-3. One patient who cerebral infarction developed during COVID-19 hospitalizing, and underwent revascularization according to PCS
花野秀行1, 青木吏絵2, 安田高志1, 黒川幸子1, 陳佑佳1, 今井正明2, 徳岡健太郎1, 小田真理2, 坂巻文雄3, 野川茂1
Neurological Therapeutics 37(6): S239-S239, 2020.
Japanese Article OD8-4. The 61 years old men who acute encephalopathy developed in a COVID-19 pneumonia treatment process, and were treated effectively with steroid pulse therapy
堀内碧, 本郷悠
Neurological Therapeutics 37(6): S239-S239, 2020.
Japanese Article OD8-5. Histories of treatment in our hospital of patients with COVID-19 pneumonia to have against a backdrop of Parkinson disease
角替麻里絵, 石山浩之, 石井淳子, 比谷里美, 乾涼磨, 塩見悠真, 中澤晋作, 黒田健仁, 藤原悟, 前川嵩太, 村上泰隆, 尾原信行, 吉村元, 幸原伸夫, 川本未知
Neurological Therapeutics 37(6): S240-S240, 2020.
Japanese Article OD9-1. Two cases of autoimmune meningoencephalitis with the immune checkpoint inhibitor in our hospital
水上健1, 後藤恵1, 内田大達2, 軸丸美香1, 木村成志1, 松原悦朗1
Neurological Therapeutics 37(6): S241-S241, 2020.
Japanese Article OD9-2. Two cases of the drug-related encephalopathy with the immune checkpoint inhibitor
毛利尚裕1, 青木真一郎2, 小池春樹1, 勝野雅央1
Neurological Therapeutics 37(6): S241-S241, 2020.
Japanese Article OD9-3. One case of the drug-related encephalopathy by the ceftriaxone which presented schizophrenia-like neurologic manifestation
瀧瀬康洋, 新村浩透
Neurological Therapeutics 37(6): S241-S241, 2020.
Japanese Article OD9-4. One patient whom central alveolar hypoventilation developed in by etizolam of the conventional dose during pregabalin internal use
後藤公文1, 正島弘隆2, 田中達也2, 吉田昌人3
Neurological Therapeutics 37(6): S241-S241, 2020.
Japanese Article OD9-5. One case of the chronic migraine headache that tardive akathisia was seen in in Brexpiprazole
菊井祥二, 宮原淳一, 杉山華子, 孝橋睦生, 太田久仁子, 團野大介, 柏谷嘉宏, 竹島多賀夫
Neurological Therapeutics 37(6): S242-S242, 2020.
Japanese Article OD9-6. One case of the adrenoleukodystrophy which produced granulocytopenia and anemia due to the copper deficiency after the zinc preparation administration
湊川みつ子, 竹内千仙, 大迫美穂, 望月葉子
Neurological Therapeutics 37(6): S242-S242, 2020.
Japanese Article OD9-7. Generalised convulsion due to the low Mg blood symptom that Proton pump inhibitor internal use was regarded as precipitants
井上雅史, 礒西淳, 内孝文, 木原英雄, 松嶋茉莉, 今村友美, 村田眞由美, 紺野晋吾, 杉本英樹, 藤岡俊樹
Neurological Therapeutics 37(6): S242-S242, 2020.
Japanese Article OD10-1. Electrophysiological influence to the skeletal muscle neuromuscular junction of the adrenalin beta 2 receptor spur
岸雅彦1, 森秀一2, 重本和宏2
Neurological Therapeutics 37(6): S243-S243, 2020.
Japanese Article OD10-2. One case of Lambert-Eaton syndrome (LEMS) who had the SAPHO syndrome
榊原健二, 川畑和也, 熱田直樹, 勝野雅央
Neurological Therapeutics 37(6): S243-S243, 2020.
Japanese Article OD10-3. A 76 years old women case of MuSK antibody, AChR antibody double positive MG: Association between change and treatment response of the antibody level
伊崎祥子, 原渉, 王子聡, 野村恭一, 海田賢一
Neurological Therapeutics 37(6): S243-S243, 2020.
Japanese Article OD10-4. One case of the Graves' disease merger serum reaction that obtained symptom remission by the excision of the swelling thymus with the FDG PET accumulation sthenia-negative myasthenia gravis
松本菜見子1, 表芳夫1, 武本麻美1, 菱川望1, 山下徹1, 都地友紘2, 阿部康二1
Neurological Therapeutics 37(6): S243-S243, 2020.
Japanese Article OD10-5. One patient whom myasthenia gravis was given transvenous immunoglobulin therapy, and crown spastic angina developed in
柳橋優1, 岡本龍一1, 森岡治美1, 澤田雅裕1, 松本新吾2, 池田隆徳2, 狩野修1
Neurological Therapeutics 37(6): S244-S244, 2020.
Japanese Article OD10-6. One patient who was complicated with aplasia pure red cell for thymoma merger myasthenia gravis, and received cyclosporine monotherapy
松嶋茉莉1, 紺野晋吾1, 礒西淳1, 内孝文1, 木原英雄1, 杉本英樹1, 森有紀2, 藤岡俊樹1
Neurological Therapeutics 37(6): S244-S244, 2020.
Japanese Article OD10-7. One case who had the polyangiitis-related granulomatosis acidophilic for myasthenia gravis
内孝文1, 紺野晋吾1, 木原英雄1, 松嶋茉莉1, 杉本英樹1, 大原関利章1,2, 高橋啓2, 藤岡俊樹1
Neurological Therapeutics 37(6): S244-S244, 2020.
Japanese Article OD11-1. Long-term sighting of the mirtazapine mefloquine combination for the progressive multifocal leukoencephalopathy that occurred during low-dose PSL singularity internal use
池田桂1, 中里良彦1, 横山立1, 大田一路1, 高橋一司1, 石澤圭介3, 野村恭一2, 山元敏正1
Neurological Therapeutics 37(6): S245-S245, 2020.
Japanese Article OD11-2. One case of the young woman that progressive multifocal leukoencephalopathy became clear with a diagnosis of the combined immunodeficiency disease
岩見昂亮1, 松島理明1, 長井梓1, 白井慎一1, 中久保祥2, 岩田育子1, 山田雅文3, 矢部一郎1
Neurological Therapeutics 37(6): S245-S245, 2020.
Japanese Article OD11-4. It is one patient who had the brain abscess for the liver abscess that spinal fluid culture is negative, and was able to detect origin bacteria by liver drainage
遠藤芳徳, 白藤法道, 勝木歩, 佐々木宏仁, 山口智久, 榎本崇一, 井川正道, 山村修, 濱野忠則
Neurological Therapeutics 37(6): S245-S245, 2020.
Japanese Article OD11-5. Tardive epidural abscess after the cervical spine vertebral arch plastic surgery that accepted improvement by medical treatment, one case of the abscess in the spinal cord marrow
松岡千紘, 安田怜, 松浦啓, 水野敏樹
Neurological Therapeutics 37(6): S246-S246, 2020.
Japanese Article OD11-6. One case of the subdural abscess found in central fissure
奥田理沙, 川崎一史, 戸叶美枝子, 横山立, 光藤尚, 中里良彦, 山元敏正
Neurological Therapeutics 37(6): S246-S246, 2020.
Japanese Article OD12-1. 38 years old men case of intractable CIDP where we introduced subcutaneous injection immunoglobulin therapy into
兼元みずき, 矢野怜, 稗田宗太郎, 小野賢二郎
Neurological Therapeutics 37(6): S247-S247, 2020.
Japanese Article OD12-2. Two examination that introduced SCIg into prevention of recurrence of CIDP, but were not as effective
布施彰久1, 北薗久雄1, 徳安大輝2, 安部恭嗣2, 相馬裕樹1, 野崎博之1
Neurological Therapeutics 37(6): S247-S247, 2020.
Japanese Article OD12-3. One case of multi-nest characteristics demyelination sexual sensation motor type neuropathy (MADSAM) which a significant radicular thickening was detected, and racked its brains about a diagnosis
木村愛美1, 水野昌宣1, 小池春樹2, 勝野雅央2, 前田哲也1
Neurological Therapeutics 37(6): S247-S247, 2020.
Japanese Article OD12-4. One case of the IgG type antiGD1b antibody-positive autoimmune neuropathy which occurred with cytomegalovirus infection
林和孝1, 水谷泰彰1, 前田利樹1, 新美芳樹1, 島さゆり1, 植田晃広1, 伊藤瑞規1, 内堀歩2, 千葉厚郎2, 渡辺宏久1
Neurological Therapeutics 37(6): S247-S247, 2020.
Japanese Article OD12-5. One case that IVIg therapy was effective for the GQ1b IgG antibody-positive neuralgic amyotrophy-like symptom which occurred associated with hepatitis E
川邉清一, 岡本龍一, 小川麻喜子, 蝦名潤哉, 渋川茉莉, 花城里依, 村田貴代子, 池田憲, 狩野修
Neurological Therapeutics 37(6): S248-S248, 2020.
Japanese Article OD12-6. 68 years old women with Bickerstaff brain-stem encephalitis case who had the Takotsubo Cardiomyopathy
木村瑞希, 橋口俊太, 田中健一, 高橋慶太, 宮地洋輔, 上木英人, 土井宏, 竹内英之, 田中章景
Neurological Therapeutics 37(6): S248-S248, 2020.
Japanese Article OD13-1. Domestic use results all cases investigation of the spinal muscular atrophy therapeutic drug Nusinersen: Intermediate total report
綿谷崇史, 高崎さくら, 星野美鈴, 牧岡大器, 中村源州, 松田尚人
Neurological Therapeutics 37(6): S249-S249, 2020.
Japanese Article OD13-2. About Nusinersen treatment for the spinal muscular atrophy in our hospital
嶋崎晴雄1,2, 益子貴史2, 藤本茂2
Neurological Therapeutics 37(6): S249-S249, 2020.
Japanese Article OD13-3. An effect of the Nusinersen in the infants who started treatment before onset of spinal muscular atrophy clinical manifestations: Results of the NURTURE study
Monique M Ryan, Janbernd Kirschner, Richard S Finkel, Kathryn J Swoboda, Thomas O Crawford, Darryl C De Vivo, Enrico Bertini, Wuh-Liang Hwu, Richard Foster, Daniela Ramirez-Schrempp, Russell Chin, Wildon Farwell
Neurological Therapeutics 37(6): S249-S249, 2020.
Japanese Article OD13-4. The Nusinersen treatment in patients with adolescent tardive spinal muscular atrophy: Chronic administration in the CS2/CS12/SHINE study
齋藤加代子1, John W Day2, Kathryn J Swoboda2, Basil T Darras2, Claudia A Chiriboga2, Susan T Iannaccone2, Darryl C De Vivo2, Nicolas Deconinck2, Richard S Finkel2, Mar Tulinius2, Jacqueline Montes2, Laurence Mignon2, Peng Sun2, Ishir Bhan2, Sarah Gheuens2, Daniela Ramirez-Schrempp2, Sandra P Reyna2, Janice Wong2, Wildon Farwell2
Neurological Therapeutics 37(6): S249-S249, 2020.
Japanese Article OD13-5. Examination about the effectiveness of the Nusinersen for three old spinal muscular atrophy
奥村学1,2, 美谷島真洋1, 尾澤一樹1, 森泉輝哉1, 高曽根健1, 上野晃弘1, 関島良樹1
Neurological Therapeutics 37(6): S250-S250, 2020.
Japanese Article OD13-6. The comparison of frequencies of the hydrocephalus by the incidence presence or absence of spinal muscular atrophy: Study using the American electronic medical chart
Susan Hall, Nasha Wang, Maneesh Juneja, Ishir Bhan, Claudia Prada, Dayle James, Stacie Lallier, Susan Eaton, Anne Dilley
Neurological Therapeutics 37(6): S250-S250, 2020.
Japanese Article OD14-1. Long-term walk function maintenance effect of the HAL in patients with amyotrophic lateral sclerosis
森岡治美1, 川邉清一1, 村田貴代子1, 平山剛久1, 柳橋優1, 花城里依1, 給前まや1, 蝦名潤哉1, 渋川茉莉1, 岡本龍一1, 小川麻喜子1, 杉澤樹2, 福田大空2, 内昌之2, 海老原覚2, 村上義孝3, 狩野修1
Neurological Therapeutics 37(6): S251-S251, 2020.
Japanese Article OD14-2. Effect of treatment of the cyborg type robot HAL for the walk function of the amyotrophic lateral sclerosis
村田貴代子1, 森岡治美1, 杉澤樹2, 福田大空2, 内昌之2, 小川麻喜子1, 岡本龍一1, 渋川茉莉1, 蝦名潤哉1, 給前まや1, 花城里依1, 柳橋優1, 平山剛久1, 川邉清一1, 海老原覚2, 中島孝3, 狩野修1
Neurological Therapeutics 37(6): S251-S251, 2020.
Japanese Article OD14-3. Rehabilitation effect of robotic suit curara(R) on SCD, MSA-C patients
松嶋聡1, 丸山陽一2, 水上憲明3, 鉄矢美紀雄3,4, 橋本稔4, 吉田邦広1,5
Neurological Therapeutics 37(6): S251-S251, 2020.
Japanese Article OD14-4. Aftercare by orthopedics surgery and Hybrid Assistive Limb (HAL) of patients with neuromuscular disorders: Case report
松井彩乃1, 野澤大輔2, 安部哲哉2, 原友紀2, 清水如代3
Neurological Therapeutics 37(6): S251-S251, 2020.
Japanese Article OD14-5. One case of the multiple system atrophy (MSA) that upper respiratory tract imaging by 4DCT was useful in a breathing tight military ration
菊地豊1, 中澤将城1, 宮川哲夫2, 白吉孝匡1, 金井光康1, 古井啓1, 池田佳生3, 美原盤1
Neurological Therapeutics 37(6): S252-S252, 2020.
Japanese Article OD14-6. The 85 years old women case who had the onset with abnormal posture, and were treated effectively with ovarian tumor enucleation for the paraneoplasic motor neurone disease due to ovarian tumor
伊佐早健司1, 菊池崇之1, 佐々木直1, 長谷川泰弘1,2, 山野嘉久1
Neurological Therapeutics 37(6): S252-S252, 2020.
Japanese Article OD14-7. Recent tendency in our hospital autopsy agreement acquisition case
駒井清暢
Neurological Therapeutics 37(6): S252-S252, 2020.
Japanese Article OD15-1. Examination of the cerebroprotection effect of the mesenchyma system stem cell derived from iPSC in the rat local cerebral ischemia model
荒川将史1, 仁藤智香子1, 宮川世志幸3, 坂本悠記1, 高橋史朗1, 笠原優子3, 須田智1, 岡田尚巳2, 木村和美1
Neurological Therapeutics 37(6): S253-S253, 2020.
Japanese Article OD15-2. Establishment ... of the new technology to produce nerve cells after the cerebral infarction newly, and to induce nerve cells from ... intracerebral glia cells aiming at reproduction
山下徹, 商敬偉, 中野由美子, 森原隆太, 佐藤恒太, 武本麻美, 菱川望, 太田康之, 阿部康二
Neurological Therapeutics 37(6): S253-S253, 2020.
Japanese Article OD15-3. Effect on proteolyses molecular mechanism of the ischemic brain by the stem cell transplant
田所功, 福井裕介, 山下徹, 劉夏, 角田慶一郎, 商敬偉, 表芳夫, 武本麻美, 菱川望, 太田康之, 阿部康二
Neurological Therapeutics 37(6): S253-S253, 2020.
Japanese Article OD15-4. A weight loss and prognosis in patients with acute phase cerebral infarction
大山健, 大塚健司, 斎藤勇紀, 辻裕丈, 中藪幹也, 小林靖
Neurological Therapeutics 37(6): S253-S253, 2020.
Japanese Article OD15-5. Clinical examination of the infarction of spinal cord 3 case that we experienced in our hospital in the past 10 years
越川浩明, 関香奈子, 石川広明, 鈴木仁, 栗田正, 作石かおり
Neurological Therapeutics 37(6): S254-S254, 2020.
Japanese Article OD15-6. One case of the spinal dura mater arteriovenous fistulas which accepted hemoid cerebral fluid at acute exacerbation
平賀経太1, 鈴木将史1, 泉孝嗣2, 熱田直樹1, 勝野雅央1
Neurological Therapeutics 37(6): S254-S254, 2020.
Japanese Article OD15-7. One case of the central nervous system malignant lymphoma which presented slowly-progressive atypical cerebral infarction-like views
村手健一郎1, 加藤邦尚1, 新美芳樹1, 島さゆり1, 入山智沙子2, 植田晃広1, 伊藤瑞規1, 中原一郎3, 冨田章裕2, 渡辺宏久1
Neurological Therapeutics 37(6): S254-S254, 2020.
Japanese Article OD16-1. One case of antiNMDA receptor encephalitis that obtained a good outcome by early aggressive multidisciplinary immune therapy in a short term
深沢良輔, 長正訓, 日高幸宏, 武澤秀理, 藤井明弘
Neurological Therapeutics 37(6): S255-S255, 2020.
Japanese Article OD16-2. Examination of the higher brain function disorder of the Hashimoto encephalopathy
武久康1, 川口洋子1, 鶴川春佳2, 守本佐保2, 小川さおり2, 米田誠3
Neurological Therapeutics 37(6): S255-S255, 2020.
Japanese Article OD16-3. The effect that Yokukansan gives to tau protein phosphorylation, oligomerizing internal
白藤法道1, 濱野忠則1,2
Neurological Therapeutics 37(6): S255-S255, 2020.
Japanese Article OD16-4. About the long-term course of patients with inclusion body disease in the nerve nucleus which presented various neurologic symptoms and cognitive dysfunction
井上雅史1, 磯西淳1, 内孝文1, 木原英雄1, 松嶋茉莉1, 今村友美1, 村田眞由美1, 紺野晋吾1, 杉本英樹1, 曽根淳2, 藤岡俊樹1
Neurological Therapeutics 37(6): S255-S255, 2020.
Japanese Article OD16-5. Examination of the effect on prescription situation of the new sleeping drug and hospitalized fall fall accident
木村正志1, 水原亮1, 黒川拓也1, 坂田奈津枝1, 長谷川孝代2, 結城奈津子3, 吉岡亮3
Neurological Therapeutics 37(6): S256-S256, 2020.
Japanese Article OD16-6. About the effect that the rounds of the dementia care support team give for duties of the floor nurse
吉井康裕1, 林弘毅2, 望月強併3
Neurological Therapeutics 37(6): S256-S256, 2020.
Japanese Article OD16-7. Is not only thing - BPSD where a dementia care team can intervene in in our hospital which is a hospital for acute phase; ...
北薗久雄1, 高畑良子2, 鳥海幸恵2, 斉藤久美子3, 安部恭嗣1, 相馬裕樹1, 布施彰久1, 甲斐瑞恵2, 古山美佐2, 野崎博之1
Neurological Therapeutics 37(6): S256-S256, 2020.
Japanese Article OD17-1. Examination of the vascular endothelium function in the multiple sclerosis
千崎健佑, 岡田陽子, 武井聡子, 三浦史郎, 越智雅之, 越智博文, 伊賀瀬道也, 大八木保政
Neurological Therapeutics 37(6): S257-S257, 2020.
Japanese Article OD17-2. One case of the multiple sclerosis that psoriasis vulgaris was induced with interferon-beta: Histories of treatment with the dimethyl fumaric acid
王子聡1, 宮内敦生1, 杉本恒平1, 田中覚1, 伊崎祥子1, 深浦彦彰1, 人見勝博2, 福田知雄2, 野村恭一1, 海田賢一1
Neurological Therapeutics 37(6): S257-S257, 2020.
Japanese Article OD17-3. One case of the relapsing-remitting multiple sclerosis that space extension administration was effective for a headache after the natalizumab administration
岡田和将, 成毛哲思, 東盛雄政, 山本燎, 岩中行己男, 橋本智代, 大成圭子
Neurological Therapeutics 37(6): S257-S257, 2020.
Japanese Article OD17-4. The effectiveness of the eculizumab in the rituximab previous treatment patients in the PREVENT study for the neuromyelitis optica and safety
藤原一男1,2, Michael Levy3, Achim Berthele4, 中島一郎5, Dean M Wingerchuk6
Neurological Therapeutics 37(6): S257-S257, 2020.
Japanese Article OD18-1. Discriminant usefulness by the cerebral fluid lactic acid level measurement with the blood gas apparatus in patients with meningitis
内藤裕之, 杉本太路, 阿部貴文, 石川若芸, 儀賀麻由実, 河野智之, 野村栄一
Neurological Therapeutics 37(6): S258-S258, 2020.
Japanese Article OD18-2. One patient who repeated bacterial meningitis thought about according to the inner ear malformation after the adults
山口智子, 横山立, 大田一路, 瀬尾和秀, 川崎一史, 池田桂, 中里良彦, 田村直俊, 山元敏正
Neurological Therapeutics 37(6): S258-S258, 2020.
Japanese Article OD18-3. One case of the recurrent bacterial meningitis that led to a diagnosis of the nose-related liquorrhea with a large quantity of nasal discharges
鷹尾直誠, 櫻井謙三, 日野栄絵, 山野嘉久
Neurological Therapeutics 37(6): S258-S258, 2020.
Japanese Article OD18-4. One case of pneumococcal meningitis that there were no rises in cerebral fluid cell count in
加藤正義1, 清川哲郎1, 高橋海1, 井上義博2, 前田哲也1
Neurological Therapeutics 37(6): S258-S258, 2020.
Japanese Article OD18-5. The 79 years old women case who started from dental mandibular osteomyelitis, and presented with masticatory muscles crack abscess, bacterial meningitis and a cavernous sinus syndrome
河野優
Neurological Therapeutics 37(6): S259-S259, 2020.
Japanese Article OD18-6. The 41 years old women with aspergillosis meningitis case that occurred with severe autoimmune hepatitis
給前まや1, 蝦名潤哉1, 花城里依1, 川邉清一1, 吉峰尚幸2, 狩野修1
Neurological Therapeutics 37(6): S259-S259, 2020.
Japanese Article OD18-7. One case of the EGFR mutation in the gene-positive lung adenocarcinoma where meningeal carcinoma responded to Osimertinib
興津雅人1, 蕨陽子1, 清水俊夫1, 松尾健2, 吉川拓磨3, 小原徹也3, 磯崎英治1
Neurological Therapeutics 37(6): S259-S259, 2020.
Japanese Article AOM1-1. About an activity of "ALS clinic" for the purpose of the multi-type of job cooperation practice
杉澤樹1, 枩本智子2, 山下雅美2, 石田みちる3, 小野澤圭子2, 渕本雅昭2, 近藤亜紀子3, 松本幸則3, 五月女祐一4, 鷲澤尚宏4, 狩野修5, 海老原覚1
Neurological Therapeutics 37(6): S260-S260, 2020.
Japanese Article AOM1-2. As for the bronchodilatation under the tracheotomy lower intermittent positive pressure ventilation, significant in the amyotrophic lateral sclerosis
芝崎伸彦1,2, 小西かおる2, 宮川哲夫3, 沼山貴也4
Neurological Therapeutics 37(6): S260-S260, 2020.
Japanese Article AOM1-3. About an abdominal upheaval power and the relations with the respiratory function to be able to establish amyotrophic lateral sclerosis
大戸恵介1,3, 阿部達哉2, 宮川哲夫3, 小森哲夫2
Neurological Therapeutics 37(6): S260-S260, 2020.
Japanese Article AOM2-1. Difficult feeling of the nurse working at the home care support medical office in the at-home end-of-life care
湯本美穂1, 田中幸子2
Neurological Therapeutics 37(6): S261-S261, 2020.
Japanese Article AOM2-2. Examination of the body function evaluation associated with the FIM walk independence degree in the autoimmune disease inpatient
山内真哉1, 笹沼直樹1, 児玉典彦2, 内山侑紀2, 道免和久2
Neurological Therapeutics 37(6): S261-S261, 2020.
Japanese Article AOM2-3. One case of the hospitalization medical treatment Parkinson's disease which significant orthostatic hypotension was improved by gross movement in the aggressive gene locus and was at home and returned to
柳原唯人1, 丸川章1, 織田雅也2, 和泉唯信3
Neurological Therapeutics 37(6): S261-S261, 2020.
Japanese Article AOM2-4. Examination of the harness making time in the person with Charcot-Marie-Tooth disease
畔上佳広1, 毛利かおり1, 大野智彬2, 安藤哲朗2
Neurological Therapeutics 37(6): S261-S261, 2020.
Japanese Article AOM2-5. Association between cognitive function and brain small vessel disease MRI score in the forgetfulness outpatient
松田佳奈1,2, 新堂晃大2, 伊井裕一郎2, 上田有紀人1, 田部井賢一2, 石川英洋2, 松浦慶太2, 吉丸公子2, 谷口彰2, 加藤奈津子2, 田村麻子2, 佐藤正之2, 冨本秀和2
Neurological Therapeutics 37(6): S262-S262, 2020.
Japanese Article AOM2-6. System to notify of the abnormality of the electrocardiogram monitor by the light from the frame with the glasses type device
河野由江1, 辰元宗人1, 鈴木佳世子1, 平田幸一2, 種市洋1,3, 窪田敬一4
Neurological Therapeutics 37(6): S262-S262, 2020.
Japanese Article OM1-1. Examination of the factor related to fatigue at diet of patients with amyotrophic lateral sclerosis that we can ingest
山本悦子1, 仲俣菜都美1, 間嶋満1, 倉林均1, 中里良彦2, 山元敏正2
Neurological Therapeutics 37(6): S263-S263, 2020.
Japanese Article OM1-2. Progress report 6 of the Edaravone identification use results investigation (amyotrophic lateral sclerosis)
吉村健太1, 石崎薫1, 吉田健悟1, 松田雅雄1, 河口裕1, 幸敏志1, 祖父江元2
Neurological Therapeutics 37(6): S263-S263, 2020.
Japanese Article OM1-3. Examination of the acute phase rehabilitation for patients with antiNMDA receptor encephalitis
山本幸希子1, 安藤哲朗2
Neurological Therapeutics 37(6): S263-S263, 2020.
Japanese Article OM1-4. Physical therapy experience for patients with neuromyelitis optica during pregnancy
瀬尾哲1, 山内真哉1, 内山侑紀2, 児玉典彦2, 道免和久3
Neurological Therapeutics 37(6): S263-S263, 2020.
Japanese Article OM1-5. One case of Guillain-Barre syndrome that became hard to sing songs with a decreased respiratory function
進藤あかり1, 下山渉太1, 内孝文2, 藤岡俊樹2
Neurological Therapeutics 37(6): S264-S264, 2020.
Japanese Article OM1-6. Six cases of the essential tremor which evaluated a positional tremor using VibSensor(R)
角田賢史1, 伊藤恒2, 青木蕉2, 福武滋2, 小渡貴司2, 山本一徹3
Neurological Therapeutics 37(6): S264-S264, 2020.
Japanese Article OM1-7. Two examination of SCA6 which accepted a difference for an effect of the intensive rehabilitation for a short term
三浦吾郎1, 桜井和美1, 松嶋聡2
Neurological Therapeutics 37(6): S264-S264, 2020.
Japanese Article OM1-8. 1 elderly person with cerebrovascular disorder case that improvement of the balance ability was found in by exercise image intervention
中泉1, 織田雅也2, 斎藤浩二1, 今田雄二郎1, 花本侑治1, 堤大祐1, 畠原翔太1, 小林幸枝1, 伊藤聖2, 和泉唯信3
Neurological Therapeutics 37(6): S264-S264, 2020.
Japanese Article OM1-9. The concentrated kinesitherapy for the pure cerebellum type spinocerebellar degeneration improves a cognitive function
嶋本稔也1, 内野克尚2, 森麗2, 小出達也2, 飯山準一3, 野島健碁1, 本島拓哉1, 鳥井原賢1, 遠山由香1, 内野誠2
Neurological Therapeutics 37(6): S265-S265, 2020.
Japanese Article OM1-10. Examination of the quantitative evaluation of the walk lower limbs sense of cooperation for the pure cerebellum type spinocerebellar degeneration
野島健碁1, 嶋本稔也1, 内野克尚2, 松原誠仁3, 森麗2, 小出達也2, 福永貴之1, 本島拓哉1, 鳥井原賢1, 遠山由香1, 内野誠2
Neurological Therapeutics 37(6): S265-S265, 2020.
Japanese Article OM1-11. 1 case of PSP-PGF which we drew back by combination of rTMS and rehabilitation, and a foot reduced
澤田誠1, 土居充2, 丸山康徳1, 加藤保1, 下田光太郎2
Neurological Therapeutics 37(6): S265-S265, 2020.
Japanese Article OM1-12. Case of patients with dementia that led to diet intake increase by hospitalization environment adjustment
相馬ひとみ, 藤岡俊樹
Neurological Therapeutics 37(6): S265-S265, 2020.
Japanese Article OM1-13. Patients with dementia that initiative improved by musical therapy
渡邉典子1, 藤岡俊樹2, 吉野彩香3, 和田麻希子4, 勝部良子1, 荒井裕子1, 相馬ひとみ1, 小田切綾5
Neurological Therapeutics 37(6): S266-S266, 2020.
▲